For help on how to get the results you want, see our search tips.
58 results
Referral type
Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter
Article 31 referrals Remove Article 31 referrals filter
Referral safety status
Yes Remove Yes filter
Categories
Human Remove Human filter
-
List item
Referral: Valproate
Valproic acid/valproate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 26/08/2010, Last updated: 29/04/2011 -
List item
Referral: Modafinil
modafinil, associated names: Modasomil, Modiodal, Provigil, Vigil, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 27/01/2011, Last updated: 26/04/2011 -
List item
Referral: Octagam
human normal immunoglobulin 5% and 10%, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 30/05/2011, Last updated: 26/04/2011 -
List item
Referral: Dextropropoxyphene
dextropropoxyphene, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 14/06/2010, Last updated: 07/04/2011 -
List item
Referral: Gadolinium-containing contrast agents
associated names: Omniscan, Magnevist, Magnegita, Gado-MRT ratiopharm, Primovist, MultiHance, Dotarem, ProHance, Gadovist, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 06/12/2010 -
List item
Referral: Methylphenidate
methylphenidate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 27/05/2009, Last updated: 22/09/2010 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 21/11/2008 -
List item
Referral: Norfloxacin
norfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 19/11/2008, Last updated: 24/07/2008 -
List item
Referral: Ergot-derived dopamine agonists
bromocriptine, cabergoline, dihydroergocryptine, lisuride and pergolide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 26/06/2008 -
List item
Referral: Piroxicam
piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008 -
List item
Referral: Agreal
veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008 -
List item
Referral: Bicalutamide 150 mg
bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007 -
List item
Referral: Elidel
pimecrolimus, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2006, Last updated: 29/08/2006 -
List item
Referral: Celecoxib
celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Lumiracoxib
lumiracoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Paroxetine
Paroxetine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 09/12/2004, EC decision date: 29/03/2005, Last updated: 22/11/2005 -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005 -
List item
Referral: Loratadine
loratadine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004 -
List item
Referral: Loratadine and pseudoephedrine
loratadine / pseudoephedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004 -
List item
Referral: Celecoxib
celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 29/04/2004, Last updated: 09/06/2004 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/02/2004, EC decision date: 28/04/2004, Last updated: 09/06/2004 -
List item
Referral: Rofecoxib
Rofecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 09/06/2004 -
List item
Referral: Nimesulide
nimesulide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2003, EC decision date: 26/04/2004, Last updated: 13/05/2004 -
List item
Referral: Calcitonins
calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/11/2002, EC decision date: 12/06/2003, Last updated: 02/03/2004